FDA 510(k) · Masimo

K081659: RAINBOW ADHESIVE CO-OXIMETRY SENSOR, MODELS RI-25-L, RI-25, RI-20 AND RI-20-L (Masimo Corporation)

Masimo Corporation received FDA 510(k) K081659 for RAINBOW ADHESIVE CO-OXIMETRY SENSOR, MODELS RI-25-L, RI-25, RI-20 AND RI-20-L, with a decision date of Sep 9, 2008 (substantially equivalent).

Prescription or OTC: Unknown (no FDA document we parsed states it).

FDA record for K081659FDA summary or statement (PDF)

FDA facts

Official fields for K081659
FDA numberK081659
Pathway510(k)
ApplicantMasimo Corporation
Device nameRAINBOW ADHESIVE CO-OXIMETRY SENSOR, MODELS RI-25-L, RI-25, RI-20 AND RI-20-L
Product codeDQA: Oximeter
Regulation (21 CFR)870.2700
Device classClass 2
Date receivedJun 12, 2008
Decision dateSep 9, 2008
DecisionSubstantially Equivalent (SESE)
510(k) typeTraditional

Source: openFDA device 510(k) data, data through Oct 26, 2026.

Indications for use parsed from FDA documents

510(k) Number (if known): Device Name: Rainbow Adhesive Pulse CO-Oximeter Sensors Indications For Use: The Rainbow Adhesive Sensors are indicated for the continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO 2), pulse rate, carboxyhemoglobin saturation (SpCO), methemoglobin saturation (SpMet), and/or total hemoglobin (SpHb). The Rainbow Adhesive Sensors are indicated for use with adult, pediatric, and neonatal patients during both no motion and motion conditions, and for patients who are well or poorly perfused in hospitals, hospital-type facilities, mobile, and home environments. (Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices 510(k) Number: __ _ _ _ __ _ Prescription Use X AND/OR Over-The-Counter Use (Per 21 CFR 801.109 Subpart D) (Per 21 CFR 801.109 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) K081659, Response 8128108

Extracted automatically from FDA's 510(k) summary. It can contain extraction errors and is not a verified quote. Read the wording in the FDA PDF before relying on it.

Predicates parsed from FDA documents

FDA numbers found next to the word "predicate" in the summary. The list can include reference devices; check the PDF for which device is the primary predicate.

  • K080238 MASIMO RAINBOW SET RADICAL 7 PULSE CO-O… (Masimo)
  • K071024 MODIFICATION TO: RAINBOW ADHESIVE CO-OX… (Masimo)

Later records that cite K081659

  • K090165 RAINBOW RESPOSABLE PULSE CO-OXIMETER SENSORS, MODELS R2C-25, R2-25, R2C-20 AND R2-20 (Masimo, Jul 9, 2009, DQA)

ChatPPG interpretation

A 510(k) decision of "substantially equivalent" means FDA found the device as safe and effective as a legally marketed predicate. FDA's word for this is cleared, not approved. The clearance covers the device and indications in this submission; it does not extend to other features or versions of the same product that were not part of it. See FDA cleared vs approved.

Product code DQA is "Oximeter", class 2, 21 CFR 870.2700.

Our labels for filtering: claim SpO2 / pulse oximetry, sensor Finger PPG. These are heuristics, not FDA fields.